Hansen Tine W, Thijs Lutgarde, Boggia José, Li Yan, Kikuya Masahiro, Björklund-Bodegård Kristina, Richart Tom, Ohkubo Takayoshi, Jeppesen Jørgen, Torp-Pedersen Christian, Lind Lars, Sandoya Edgardo, Imai Yutaka, Wang Jiguang, Ibsen Hans, O'Brien Eoin, Staessen Jan A
Research Center for Prevention and Health and Department of Clinical Physiology, Faculty of Health Sciences, Hvidovre University Hospital, Copenhagen, Denmark.
Hypertension. 2008 Aug;52(2):229-35. doi: 10.1161/HYPERTENSIONAHA.108.113191. Epub 2008 Jun 23.
The evidence relating mortality and morbidity to heart rate remains inconsistent. We performed 24-hour ambulatory blood pressure monitoring in 6928 subjects (not on beta-blockers; mean age: 56.2 years; 46.5% women) enrolled in prospective population studies in Denmark, Belgium, Japan, Sweden, Uruguay, and China. We computed standardized hazard ratios for heart rate, while stratifying for cohort, and adjusting for blood pressure and other cardiovascular risk factors. Over 9.6 years (median), 850, 325, and 493 deaths accrued for total, cardiovascular, and noncardiovascular mortality, respectively. The incidence of fatal combined with nonfatal end points was 805, 363, 439, and 324 for cardiovascular, stroke, cardiac, and coronary events, respectively. Twenty-four-hour heart rate predicted total (hazard ratio: 1.15) and noncardiovascular (hazard ratio: 1.18) mortality but not cardiovascular mortality (hazard ratio: 1.11) or any of the fatal combined with nonfatal events (hazard ratio: < or =1.02). Daytime heart rate did not predict mortality (hazard ratio: < or =1.11) or any fatal combined with nonfatal event (hazard ratio: < or =0.96). Nighttime heart rate predicted all of the mortality outcomes (hazard ratio: > or =1.15) but none of the fatal combined with nonfatal events (hazard ratio: < or =1.11). The night:day heart rate ratio predicted total (hazard ratio: 1.14) and noncardiovascular mortality (hazard ratio: 1.12) and all of the fatal combined with nonfatal events (hazard ratio: > or =1.15) with the exception of stroke (hazard ratio: 1.06). Sensitivity analyses, in which we stratified by risk factors or from which we excluded 1 cohort at a time or the events occurring within 2 years of enrollment, showed consistent results. In the general population, heart rate predicts total and noncardiovascular mortality. With the exception of the night:day heart rate ratio, heart rate did not add to the risk stratification for fatal combined with nonfatal cardiovascular events. Thus, heart rate adds little to the prediction of cardiovascular risk.
关于心率与死亡率和发病率之间的关系,证据仍然不一致。我们对丹麦、比利时、日本、瑞典、乌拉圭和中国前瞻性人群研究中纳入的6928名受试者(未服用β受体阻滞剂;平均年龄:56.2岁;46.5%为女性)进行了24小时动态血压监测。我们计算了心率的标准化风险比,同时按队列分层,并对血压和其他心血管危险因素进行了调整。在9.6年(中位数)的时间里,分别有850例、325例和493例全因死亡、心血管死亡和非心血管死亡。心血管、中风、心脏和冠状动脉事件的致命与非致命终点的发生率分别为805例、363例、439例和324例。24小时心率可预测全因(风险比:1.15)和非心血管(风险比:1.18)死亡率,但不能预测心血管死亡率(风险比:1.11)或任何致命与非致命事件(风险比:≤1.02)。日间心率不能预测死亡率(风险比:≤1.11)或任何致命与非致命事件(风险比:≤0.96)。夜间心率可预测所有死亡率结局(风险比:≥1.15),但不能预测任何致命与非致命事件(风险比:≤1.11)。夜间与日间心率比值可预测全因(风险比:1.14)和非心血管死亡率(风险比:1.12)以及所有致命与非致命事件(风险比:≥1.15),中风除外(风险比:1.06)。敏感性分析中,我们按危险因素分层,或每次排除1个队列,或排除入组后2年内发生的事件,结果一致。在一般人群中,心率可预测全因和非心血管死亡率。除夜间与日间心率比值外,心率对致命与非致命心血管事件的风险分层没有额外作用。因此心率对心血管风险的预测作用不大。